Clinical Trial Update: Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and efficacy of FMP010 malaria protein with AS01B adjuvant completed with posted results in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• AS01B (AS01B)
• FMP010 (Plasmodium falciparum malaria protein 010)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2020-06-09